or Try an Advanced Search...

    Pivotal Stocks List

    Symbol Grade Name % Change
    EXEL B Exelixis, Inc. 0.55
    CLDX C Celldex Therapeutics, Inc. 2.72
    ALIM F Alimera Sciences, Inc. 0.14
    TTOO F T2 Biosystems, Inc. 8.33
    BLRX F BioLineRx Ltd. -0.15
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major
    Related Stock Lists: Biotechnology Medicine Biopharmaceutical Cancer Clinical Development Treatment Of Cancer Acute Myeloid Leukemia Advanced Breast Cancer Age Related Macular Degeneration Antibody Drug Conjugate Autoimmune Disease Biomarkers Biopharmaceutical Development Blastoma Blindness Blood Blood Plasma Brain Tumor Breast Cancer Cancer Center

    Related ETFs - A few ETFs which own one or more of the above listed Pivotal stocks.

    Symbol Grade Name Weight
    PBE C PowerShares Dynamic Biotech & Genome 6.02
    IDNA C iShares Genomics Immunology and Healthcare ETF 4.14
    FBT D First Trust Amex Biotech Index Fund 3.43
    BBP C BioShares Biotechnology Products Fund 2.13
    XBI C SPDR S&P Biotech ETF 2.11
    View all Pivotal ETFs...
    Compare ETFs
    Compare IDNA to XBI Compare PBE to BBP Compare PBE to FBT

        Pivotal Stocks Recent News

        Date Stock Title
        May 2 EXEL Exelixis: With Patent Litigation Decision Due Soon, There Are Options
        May 2 EXEL Exelixis, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
        May 1 EXEL Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short
        May 1 EXEL Q1 2024 Exelixis Inc Earnings Call
        May 1 EXEL Exelixis Inc (EXEL) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
        May 1 EXEL Exelixis (EXEL) Q1 2024 Earnings Call Transcript
        May 1 EXEL Exelixis, Inc. (EXEL) Q1 2024 Earnings Call Transcript
        Apr 30 EXEL Exelixis down 7% as Q1 financial results disappoint
        Apr 30 EXEL Exelixis (EXEL) Reports Q1 Earnings: What Key Metrics Have to Say
        Apr 30 EXEL Exelixis Inc (EXEL) Q1 2024 Earnings: Mixed Results Amidst Restructuring Efforts
        Apr 30 EXEL Exelixis Non-GAAP EPS of $0.17 misses by $0.12, revenue of $425.2M misses by $35.27M
        Apr 30 EXEL Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update
        Apr 29 EXEL Exelixis Q1 2024 Earnings Preview
        Apr 26 EXEL Analysts Estimate Immunome, Inc. (IMNM) to Report a Decline in Earnings: What to Look Out for
        Apr 26 EXEL Merus (MRUS) Moves 7.1% Higher: Will This Strength Last?
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major
        Related Stock Lists: Biotechnology Medicine Biopharmaceutical Cancer Clinical Development Treatment Of Cancer Acute Myeloid Leukemia Advanced Breast Cancer Age Related Macular Degeneration Antibody Drug Conjugate Autoimmune Disease Biomarkers Biopharmaceutical Development Blastoma Blindness Blood Blood Plasma Brain Tumor Breast Cancer Cancer Center
        Pivotal

        Browse All Tags